Annual Secretarial Compliance Report for the financial year ended 31st March 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech Limited has submitted its Annual Secretarial Compliance Report for the financial year ended 31st March 2025, issued by Practicing Company Secretary Mr. K. Ravichandran. The report flagged four instances of non-compliance during FY25, all involving late filings with BSE that attracted fines totaling approximately Rs. 1.25 lakh (Rs. 1,25,080 including GST). These were: late filing of related party transactions (Rs. 5,900), delay in XBRL submission of last year's secretarial report (Rs. 42,480), late prior intimation of a board meeting (Rs. 11,800), and late submission of Q3 FY25 financial results due to delays in finalizing consolidated accounts of its material subsidiary Dindigul Farm Product Limited (Rs. 64,900). The company has since paid all these fines. Earlier non-compliances from FY24 (including listing approval delays with fines over Rs. 32 lakh) have been regularized. The report confirms overall compliance with secretarial standards, board processes, insider trading norms, and related party transaction approvals.
The compliance lapses are procedural in nature with modest penalties already paid — no major governance red flags. Investors should note recurring filing delays, particularly related to consolidating subsidiary financials, which may signal operational coordination issues at the subsidiary level.